|
|
Article: Ardian(R) Demonstrates Durable Blood Pressure Reduction in Hypertension Patients Treated with Symplicity(R) Catheter System(TM).
- Article from:
- PR Newswire
- Article date:
- September 25, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PALO ALTO, Calif., Sept. 25 /PRNewswire/ -- Data supporting the long-term safety and effectiveness of renal sympathetic denervation (RDN) in treating patients with chronic hypertension were presented today at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco, California. The data were presented at a late-breaking trial session and showed that patients in the study maintained a clinically significant reduction in blood pressure at one -year following treatment.
The results stemmed from the Symplicity I Trial which was the first clinical study to evaluate a catheter-based treatment for chronic hypertension. The study enrolled ...